Clinical Trial Update: Changes of Depression After First-year of Tofacitinib in RA Patients

View source ↗

Summary

This clinical trial update reports changes in depressive symptoms after one year of tofacitinib treatment in rheumatoid arthritis patients, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• XELJANZ (tofacitinib)

Snippet

Sponsor: Pfizer | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2025-04-06